Search

High intensity, high impact: tackling waiting lists one HIT at a time

A monthly high intensity theatre list in Sheffield shows how smart planning, teamwork and focus can dramatically reduce long ENT waiting lists. Finally, after many years of training, I’ve started my first consultant post – only to become part of...

A brief history of adenoidectomy - a glowing report of the post nasal space

The traditional adenoid curette more closely resembles a medieval torture device than an instrument of cure. Therefore it is not much of a surprise to learn that it has changed little since its invention almost 150 years ago. During that...

ENT clinics – 50 years of progress…?

Cocaine in abundance, eustachian tube catheterisation, and the ever-present threat of a fire in the clinic… How have things changed in the last few decades? Retired ENT surgeon, Douglas MacMillan, tells us of his experiences starting out in the late...

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

Chronic rhinosinusitis management: back to the future?

Immunology is a dim and distant medical school memory to many ENT surgeons, but the increasingly complex immunology of chronic rhinosinusitis is fascinating (honestly!). Medical management options in CRS no longer just involves saline and steroids, and we need to...

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....